Featured Announcement: LONGi Signs a Major Investment Agreement of About 19.5 Billion Yuan_Securities Times

Securities Times e-company news, LONGi: Signed a major investment agreement with a project investment of about 19.5 billion yuan; Novozyme: Novozymes medical-produced novel coronavirus antigen detection kits have completed changes to the instructions, etc.; Peking University Pharmaceuticals: The company currently has no Plans to cooperate with foreign manufacturers on drugs; Mingde Bio: the company’s new crown antigen detection reagent has submitted a registration application to the State Food and Drug Administration; BGI: a holding subsidiary’s new crown antigen detection product medical device registration certificate change; Wanfu Bio: the company’s new The approval document for the coronavirus antigen detection kit has been changed; Oriental Yuhong: Raise the prices of some of the company’s main products; Asymchem: It is expected that the operating income in the first quarter will increase by more than 150% year-on-year; Xizi Clean Energy: signed a contract for green electricity molten salt energy storage Demonstration Project Contract.